These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 705703)

  • 1. Plasminogen activator levels in plasma and urine during exercise and oral contraceptive use.
    Hedlin AM; Milojevic S; Korey A
    Thromb Haemost; 1978 Jun; 39(3):743-50. PubMed ID: 705703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic changes induced by exercise during oral contraceptive use.
    Hedlin AM; Milojevic S; Korey A
    Can J Physiol Pharmacol; 1978 Apr; 56(2):316-20. PubMed ID: 638885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibrinolytic response in women on low-dose oral contraceptive.
    Ishak R; Ahmad R; Gudum HR; Hassan K; Ang ES
    Malays J Reprod Health; 1992 Jun; 10(1):7-11. PubMed ID: 12345026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunoradiometric determination of blood/tissue plasminogen activators in thrombophilia].
    Astedt B; Fagner U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):475-9. PubMed ID: 6083913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of oral contraceptive estrogen on blood coagulation and fibrinolysis.
    Hedlin AM
    Thromb Diath Haemorrh; 1975 Apr; 33(2):370-8. PubMed ID: 1138426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of the initial level of plasminogen activator in changes in fibrinolysis].
    Andreenko GV; Liutova LV; Karabasova MA; Podorol'skaia LV; Serebriakova TN
    Fiziol Zh SSSR Im I M Sechenova; 1983 Mar; 69(3):380-5. PubMed ID: 6343132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extrinsic plasminogen activator response to exercise after a single dose of propranolol.
    el-Sayed MS
    Med Sci Sports Exerc; 1992 Mar; 24(3):327-32. PubMed ID: 1549027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise-induced fibrinolysis--fact or fiction?
    Marsh NA; Gaffney PJ
    Thromb Haemost; 1982 Oct; 48(2):201-3. PubMed ID: 6217583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic response to exercise in women using third-generation oral contraceptives.
    Weiss C; Walter B; Dorsch MF; Bärtsch P
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):563-8. PubMed ID: 16988552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin formation and dissolution in women receiving oral contraceptive drugs.
    Ball AP; McKee PA
    J Lab Clin Med; 1977 Apr; 89(4):751-62. PubMed ID: 845477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two low-dose oral contraceptives on circulating components of the coagulation and fibrinolytic systems.
    Gevers Leuven JA; Kluft C; Bertina RM; Hessel LW
    J Lab Clin Med; 1987 Jun; 109(6):631-6. PubMed ID: 3108429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of moderate and strenuous daily physical activity on fibrinolytic activity of blood: possibility of plasminogen activator stores depletion.
    Keber D; Stegnar M; Keber I; Accetto B
    Thromb Haemost; 1979 Jun; 41(4):745-55. PubMed ID: 483247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasminogen activator in nephrotic syndrome.
    Andreenko GV; Podoroldskaya LV; Polyantseva LP
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):351-5. PubMed ID: 2465229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of activated factor VII and decreased plasma protein S activity and circulating thrombomodulin during use of oral contraceptives.
    Quehenberger P; Loner U; Kapiotis S; Handler S; Schneider B; Huber J; Speiser W
    Thromb Haemost; 1996 Nov; 76(5):729-34. PubMed ID: 8950781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemostatic balance during treatment with the newest contraceptives].
    Petersen KR; Skouby SO; Sidelmann J; Jespersen J
    Ugeskr Laeger; 1994 Jan; 156(2):187-90. PubMed ID: 8296409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing the risk of oral contraceptive-induced thrombosis.
    Pizzo SV
    Drug Ther (NY); 1981 Sep; 11(9):101-8. PubMed ID: 12263495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Balance of coagulation activity with fibrinolysis during use of oral contraceptives in women with insulin-dependent diabetes mellitus.
    Petersen KR; Skouby SO; Jespersen J
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():105-11. PubMed ID: 8574252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.